Jonas Duclos is one of three co-founders and CEO of JKB Research SA. Reached a rare genetic disease, incurable and no palliative treatment existing, he endures from his teen years of excruciating pain in a continuous way. After several years of ineffective treatment trials, Jonas discovered that effectively soothes his suffering. With the consent of his doctor, Jonas began treatment with .
Now Jonas has been studying for over 20 years, becoming an expert in this plant, its industry, its applications and its potential.
Although forced to leave school at the age of 16 because of his illness, Jonas managed to join the prestigious UBS bank in Geneva following the excellent results of his aptitude test. Following this, he continued to practice in several well-known private banks in Geneva.
When was legalized in Switzerland, Jonas naturally made the decision to leave the position of wealth manager to fulfill his mission: to participate in the evolution of understanding and attitudes about the plant.
His two associates, Kevin Goetelen and Bruno Studer, sharing his vision and ambition, accompany him in his mission thanks to the unwavering commitment of a united and passionate team.
Learn more about Jonas Dulos and CBD420® in The Guardian and Business Insider.